Navigation Links
Cold-EEZE® Cold Remedy Awarded Coveted Parent Tested Parent Approved (PTPA) Seal of Approval
Date:11/17/2011

DOYLESTOWN, Pa., Nov. 17, 2011 /PRNewswire/ -- ProPhase Labs (NASDAQ: PRPH), makers of Cold-EEZE Cold Remedy, a leader in over-the-counter (OTC) homeopathic cold remedies, is excited to announce that Cold-EEZE has been awarded the Parent Tested Parent Approved (PTPA) Winner's Seal of Approval.  PTPA Media has North America's largest volunteer parent testing community, with over 40,000 parents. The seal of approval was awarded based on quality, effectiveness and value.

(Photo:  http://photos.prnewswire.com/prnh/20111117/NY09104 )

Cold-EEZE is the #1 pharmacist-recommended zinc cold remedy. Its proprietary zinc gluconate formula is clinically proven to safely and effectively reduce the duration and the severity of the symptoms of a common cold by nearly half (42%).

"This Seal of Approval reflects the high standards that we set for Cold-EEZE, and we are honored to receive this award," says Ted Karkus, Chairman and Chief Executive Officer of ProPhase Labs. "This recognition highlights the benefits and value that Cold-EEZE offers to families during the cough and cold season."

Cold-EEZE was among many entries from across North America competing to earn the PTPA™ Seal. Independent parent volunteers evaluate these products in their own homes. Therefore, PTPA winners are chosen based on merit and consumer experience – not on commercial considerations. As a result, the PTPA Media™ Seal has quickly gained recognition as an international leader in certifying consumer products for quality, effectiveness and value. PTPA's CEO and founder, Sharon Vinderine, has appeared on over 40 morning shows as a reliable source for the latest and greatest in family products. The media and parents alike trust the collective opinion that PTPA Media represents.

"At PTPA Media, we are proud to play a role in certifying innovative products that families can trust," says Vinderine. "When consumers search for our Seal of Approval on product packaging and web sites, they are essentially searching for validation from their peers.  Their peers will have objectively tested and approved these products based on their performance in a real life environment. That type of resource for families is priceless."

Cold-EEZE Cold Remedy has recently introduced a new convenient and great tasting Oral Spray version. Just two sprays of the Oral Spray deliver the same amount of cold remedy (active ingredient zinc gluconate) as one Cold-EEZE lozenge. Cold-EEZE is available at over 40,000 fine retail locations including all major food stores, drug chains and mass retailers.  To find a retailer or buy online please visit www.coldeeze.com.

About ProPhase Labs

ProPhase Labs is a diversified natural health medical science company. It is a leading marketer of the Cold-EEZE® cold remedy brand as well as other cold relief products.  Cold-EEZE® zinc gluconate lozenges are clinically proven to shorten the duration of the common cold by nearly half.  Cold-EEZE® customers include leading national retailers, food, chain drug and mass merchandise stores, wholesalers and distributors, as well as independent pharmacies.  ProPhase Labs has several wholly owned subsidiaries including a manufacturing unit, which consists of an FDA registered facility to manufacture Cold-EEZE® lozenges and fulfill other contract manufacturing opportunities.  ProPhase also owns 50% of Phusion Laboratories, LLC ("Phusion").  Phusion licenses a revolutionary proprietary technology that has the potential to improve the delivery and/or efficacy of many active ingredients or compounds.  Phusion will formulate and test products to exploit market opportunities within ProPhase's robust over-the-counter distribution channels.   For more information visit us at www.ProPhaseLabs.com.

About PTPA Media Inc.

PTPA Media provides an objective framework for appraising and promoting new products designed to enrich family living. The company's mission is to marry innovative companies with discerning consumers, to improve consumer access to quality products and services for their families and homes.

PTPA Media Contact Information: 

Janine Streiter, Tel: (905)738-1447 x240 For more information visit www.ptpamedia.com.

Media Contact:
Ilisa Wirgin/Jenny Miranda
212-999-5585
iwirgin@5wpr.com
jmiranda@5wpr.com


'/>"/>
SOURCE ProPhase Labs
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Help Your Favorite Charity Win $1,000 from Cold-EEZE®!
2. Fresenius Medical Care, N.A. Has Selected VitalRemedyMDs VitalProteinRx(TM) As Its Bar of Choice for Protein Replacement in Dialysis Patients
3. Phytomedics Inc. Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F in Rheumatoid Arthritis
4. NxStage Awarded Multi-Year Contract to Supply Atlantic Dialysis Management Services with Vasc-Alert Access Surveillance Solution
5. Masimo Awarded the American Association of Respiratory Cares 2011 Zenith Award
6. Psychemedics Awarded ISO/IEC 17025 International Accreditation
7. Life Spine Awarded Seven New Patents, Launches Six New Product Lines & Realizes 25% Sales Growth
8. ArjoHuntleigh Awarded Vascular Compression Contract With HealthTrust Purchasing Group
9. ImaginAb, Inc. Awarded $2.3 Million from the National Cancer Institute
10. Bacterin Awarded Approved Vendor Status for American Medical Concepts Network of Hospitals in the Northwest U.S.
11. Darah Medical Awarded GSA Schedule, Launches Online Store
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... Research and Markets has announced the addition of the ... ... vaccines market to grow at a CAGR of 6.83% during the ... the growth prospects of the global travel vaccines market for 2016-2020. ... from the sales of various vaccines administered to actively immunize meningococcal ...
(Date:12/8/2016)... IRIDEX Corporation (NASDAQ: IRIX ) today ... common stock, $0.01 par value (the "Offering" with such shares ... final terms of the Offering will depend on market and ... be no assurance as to whether or when the Offering ... net proceeds it will receive from this offering for working ...
(Date:12/8/2016)... , Dec. 8, 2016  The global biosurgery ... 8.8% during the forecast period of 2016 to 2021. ... by 2021 from USD 18.21 billion in 2016. The ... rising incidences of sports related injuries and spinal problems, ... rising need of effective blood loss management. ...
Breaking Medicine Technology:
(Date:12/9/2016)... , ... December 09, 2016 , ... ... at The Pierre Hotel in New York, NY, on December 3rd, to benefit ... and physicians attended the annual event, which raised over $1 million - the ...
(Date:12/8/2016)... ... December 08, 2016 , ... The Florida Hospital Tampa Wound ... Medical Society (UHMS), the leading authority in hyperbaric medicine. This accreditation identifies the ... hospitals and facilities have earned this distinction. This is the second time the ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the promotions ... Eric Hoessel to vice president of sales. , Litsinger joined Mirixa in ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... access for customers and employees that are both engaging and easy to use. ... Smart Technology, the software company revealed today its plans to roll out new ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
Breaking Medicine News(10 mins):